Hana Pharm Co., Ltd. (KRX:293480)
11,790
+80 (0.68%)
Dec 19, 2025, 3:30 PM KST
Hana Pharm Market Cap
Hana Pharm has a market cap or net worth of 209.54 billion as of December 19, 2025. Its market cap has increased by 7.67% in one year.
Market Cap
209.54B
Enterprise Value
n/a
Revenue
139.33B
Ranking
n/a
PE Ratio
5.26
Stock Price
11,790.00
Market Cap Chart
Since October 2, 2018, Hana Pharm's market cap has decreased from 537.03B to 209.54B, a decrease of -60.98%. That is a compound annual growth rate of -12.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 209.54B | 8.17% |
| Dec 30, 2024 | 193.73B | -21.86% |
| Dec 28, 2023 | 247.93B | -23.56% |
| Dec 29, 2022 | 324.36B | -9.43% |
| Dec 30, 2021 | 358.12B | -14.15% |
| Dec 30, 2020 | 417.15B | 14.19% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.22T |
| Celltrion | 40.37T |
| ALTEOGEN | 23.96T |
| ABL Bio | 10.50T |
| SK Biopharmaceuticals | 10.09T |
| Yuhan | 8.69T |
| LigaChem Biosciences | 6.25T |
| HLB Co., Ltd. | 6.10T |